Legal & General UCITS ETF ETFS Pharma Breakthrough USD ACC GB (BIGT)
|No top ten information is available at this stage|
Annual & interim reports
Before you invest, please make sure you read the documents below
Read full aim for Legal & General UCITS ETF
|Ongoing Charge (OCF/TER):||0.49%|
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
No company announcements about Legal & General UCITS ETF ETFS Pharma Breakthrough USD ACC GB were found.
© Digital Look Ltd 1998-2022. All rights reserved.
Recently viewed shares
Recently viewed investments
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.